Henrik in conversation with Darek Dwanda on MIND Foundation’s values and programs
Darek Dwanda from Enhanced Therapy Podcasts talks with Henrik Jungaberle
Inside Berlin’s MIND Foundation – values and programs
This is how Darek Dwanda described the conversation on his Enhanced Therapy Podcast website: “Berlin’s MIND Foundation is one of Europe’s largest psychedelic therapy organizations with global aspirations. MIND has a range of amazing programs for therapists, academics, and anyone else interested in new psychedelic therapies. In this episode we discuss a range of issues including European psychedelic landscape, ethics of Psychedelic-Assisted Therapies, cultural issues, issues of growth, and many other issues related to healing with psychedelics.”
We talk about the MIND Foundation programs APT – Augmented Psychotherapy Training, BEYOND EXPERIENCE integration workshop, Footsteps Online Integration program. I discuss the work of OVID Clinics in ketamine-augmented psychotherapy and treatment of depression, anxiety, OCD and PTSD. And we talk about the EPIsoDE study – a German psilocybin depression treatment study lead by Prof. Dr. Gerhard Gründer at the Central Institute of Mental Health Mannheim (with study centers in Mannheim and at the Clinic of Psychiatry and Psychotherapy of the Charité Universitätsmedizin).
Listen to this podcast here:
November, 25th, 2020
Thanks to Darek Dwanda from Enhanced Therapy Institute, Canada, for a lively conversation.
The MIND Foundation is a European non-profit science and education organization that promotes psychedelic research and therapy. Our work builds on the neurobiological and psychological potential of psychedelics to improve mental health and well-being in a clinical setting; for which the scientific base is firmly growing.
OVID works for better mental health and well-being through psychedelic therapies.The OVID Clinics provide ketamine-assisted psychotherapy and further methods for inducing non-pharmacological altered states of consciousness in the framework of high-quality psychotherapy. OVID strives to integrate serotonergic psychedelics into their therapy scheme as soon as possible legally.